Cover Image
市場調查報告書

乳房切片的全球市場:考察、機會、分析、市場佔有率,及預測

Global Breast Biopsy Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 360997
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
乳房切片的全球市場:考察、機會、分析、市場佔有率,及預測 Global Breast Biopsy Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年06月09日 內容資訊: 英文 140 Pages
簡介

全球乳房切片市場規模,預計以12.1%的年複合成長率發展,2022年之前達到7億6,900萬美元。女性的乳癌發病率的上升,成為推進全球乳房切片市場的主要原因之一。此外,等女性人口的增加,乳癌的認識的高漲的要素也。

本報告提供全球乳房切片市場相關分析,關於過去的市場趨勢,及今後的市場規模、成長率預測,種類、指導、各產品詳細趨勢,主要企業簡介與市場佔有率,各地區、主要國家市場結構、趨勢預測等調查評估。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 參數分析
  • 主要市場考察
    • 新興各國前3名
    • 收益生成區分前3名
    • 成長市場、新興趨勢前3名
    • 地區前3名
  • 競爭環境
    • 市場佔有率分析
    • 主要的成功策略
    • 案例研究:市場競爭的主要的動向
  • 波特的五力分析
  • 主要的購買標準
  • 策略性建議
  • 結論

第3章 市場決策要素

  • 推動市場要素
    • 微創手術的需求增加
    • 乳癌發病率的增加
    • 乳癌篩檢計劃數的增加
  • 阻礙市場要素
    • 乳房切片治療相關感染風險
    • 法規的問題
  • 市場機會
    • 新興各國的成長機會
    • 技術核心帶來的微創、精密手術
  • 市場課題
    • 切片檢查成本高
    • 受曝於放射線的漏洞
  • 母體市場
  • 競爭市場
  • 替代性市場

第4章 市場區隔

  • 各類型
    • 全球針乳房切片市場
      • 核心針切片檢查 (CNB)
      • 細微針吸引切片檢查 (FNAB)
      • 真空輔助下切片檢查 (VAB)
    • 全球開胸乳房切片市場
      • 切除乳房切片
      • 解剖乳房切片
  • 各指導
    • 全球乳房X光攝影誘導定位乳房切片市場
    • 全球超音波誘導乳房切片市場
    • 全球MRI誘導乳房切片市場
    • 全球及其他指導技術市場
  • 各產品
    • 全球切片穿刺針市場
    • 全球指導系統市場
    • 全球局部線市場
    • 全球其他市場

第5章 地區分析

  • 北美的乳癌切片檢查市場
    • 美國
    • 加拿大
  • 歐洲的乳癌切片檢查市場
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的乳癌切片檢查市場
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他
  • 其他的國家 (RoW)的乳癌切片檢查市場
    • 南美
    • 中東、北非 (MENA)
    • 非洲

第6章 企業簡介 (企業概要、SCOT分析、產業策略概要)

  • ANGIOTECH
  • CARDINAL HEALTH INC
  • CAREFUSION CORPORATION
  • C. R. BARD, INC
  • DEVICOR MEDICAL PRODUCTS INC.
  • DTR MEDICAL
  • HOLOGIC, INC
  • INRAD, INC
  • UK BIOPSY
  • BECTON, DICKINSON AND COMPANY
  • DEVICOR MEDICAL PRODUCTS INC.
  • ARGON MEDICAL DEVICES
  • COOK MEDICAL INCORPORATED
  • ETHICON ENDO SURGERY (JOHNSON AND JOHNSON)
  • GALINI SRL

圖表一覽

目錄
Product Code: HME-1531015

The global breast biopsy market is estimated to grow at a CAGR of 12.1% and will contribute $769 million by 2022. Rising breast cancer incidences in women's are one of the major factors that drive the global breast biopsy market. There are many other reasons such as rising women population, growing awareness regarding breast cancer and so on. Breast biopsy tests are generally used for diagnosing breast cancer and also as a checkup for other ailments in the breast, such as lump etc. and also breast cancer if identified during physical examination. There are many drivers of the global breast biopsy market. Increasing prevalence of female breast cancer is one of the major factors. The region with higher number of women's are likely to act as a growth region for this market, Asia Pacific is the growing market in breast biopsy. Breast cancer is one of the common cancers in women worldwide. More than 3 million cases worldwide are being diagnosed for cancer. This data is expected to grow in near future. Rising incidence of cancer is one of the major reasons for the growth of global breast biopsy market. Increasing technology enables to lower the pain in the biopsy procedure and hence enhances the global market. Technology is the key factor that produces highly accurate and précised machineries, which extract the cancerous area with minimal invasion and less pain. This acts as an opportunity for the growth of the global breast biopsy market.

There are chances of infectious risks related to breast biopsy, which lower the demand and acts as a restraint in the growth of global breast biopsy market. High cost of breast biopsy is the major factor that hinders the growth of global breast biopsy market. Breast biopsy requires highly qualified doctors, surgeons and other medical teams and also demands high technological advanced machineries; which all adds up to the high cost of biopsy surgery as a result of which it is not in reach of common people.

In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of world. Asia Pacific is also a growing market due to increasing awareness for breast cancer among women's is one of the major reasons for the growth in Asia Pacific market. North America is the leader in global breast biopsy. The reason for this dominance by North America is the availability of highly advanced and equipped instruments, growing awareness for breast cancer, and supportive governmental initiatives. Europe is one of the leading regions in global breast biopsy market. High female population is one of the major reasons for the growth of Europe market. Rest of the world is showing lesser growth, but awareness programs regarding breast cancer is accelerating the market.

Some of the major market players are Angiotech, Cardinal Health Inc., Carefusion Corp., Galini SRL, Ethicon Endo Surgery (Johnson and Johnson), Cook Medical Incorporated, Argon Medical Devices Becto, Dickinson and Company, UK Biopsy, Hologic, Inc., DTR Medical, etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP 3 EMERGING COUNTRIES
    • 2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. TOP 3 GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING DEMAND FOR MINIMAL INVASIVE SURGERY
    • 3.1.2. INCREASING INCIDENCE OF BREAST CANCER
    • 3.1.3. INCREASING NUMBER OF BREAST CANCER SCREENING PROGRAMS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. INFECTION RISKS RELATED TO BREAST BIOPSY PROCEDURE
    • 3.2.2. REGULATORY ISSUES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWTH OPPORTUNITY IN EMERGING COUNTRIES
    • 3.3.2. TECHNOLOGICAL INNOVATION LEADS TO LESS INVASIVE AND ACCURATE SURGERY
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGH COST OF BIOPSY
    • 3.4.2. SUSCEPTIBILITY TO RADIATION EXPOSURE
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. BY TYPE
    • 4.1.1. GLOBAL NEEDLE BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
      • 4.1.1.1. GLOBAL CORE NEEDLE BIOPSY MARKET 2014-2022 ($ MILLION)
      • 4.1.1.2. GLOBAL FINE NEEDLE ASPIRATION BIOPSY MARKET 2014-2022 ($ MILLION)
      • 4.1.1.3. GLOBAL VACUUM ASSISTED BIOPSY MARKET 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL OPEN SURGICAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
      • 4.1.2.1. GLOBAL EXCISIONAL MARKET 2014-2022 ($ MILLION)
      • 4.1.2.2. GLOBAL INCISIONAL MARKET 2014-2022 ($ MILLION)
  • 4.2. BY GUIDANCE
    • 4.2.1. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BREAST BIOPSY MARKET 2014-2022($ MILLION)
    • 4.2.2. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
    • 4.2.3. GLOBAL MRI GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
    • 4.2.4. GLOBAL OTHER GUIDANCE TECHNIQUE MARKET 2014-2022($ MILLION)
  • 4.3. BY PRODUCTS
    • 4.3.1. GLOBAL BIOPSY NEEDLES MARKET 2014-2022($ MILLION)
    • 4.3.2. GLOBAL GUIDANCE SYSTEMS MARKET 2014-2022($ MILLION)
    • 4.3.3. GLOBAL LOCALIZATION WIRES MARKET 2014-2022($ MILLION)
    • 4.3.4. GLOBAL OTHER MARKET 2014-2022($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROEGLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.4. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.5. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLDGLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILING: - (OVER, SCOT ANALYSIS, STRATEGIC REVIEW)

  • 1. ANGIOTECH
  • 2. CARDINAL HEALTH INC
  • 3. CAREFUSION CORPORATION
  • 4. C. R. BARD, INC
  • 5. DEVICOR MEDICAL PRODUCTS INC.
  • 6. DTR MEDICAL
  • 7. HOLOGIC, INC
  • 8. INRAD, INC
  • 9. UK BIOPSY
  • 10. BECTON, DICKINSON AND COMPANY
  • 11. DEVICOR MEDICAL PRODUCTS INC.
  • 12. ARGON MEDICAL DEVICES
  • 13. COOK MEDICAL INCORPORATED
  • 14. ETHICON ENDO SURGERY (JOHNSON AND JOHNSON)
  • 15. GALINI SRL

LIST OF TABLES

  • 1. GLOBAL NEEDLE BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 2. GLOBAL CORE NEEDLE BIOPSY MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL FINE NEEDLE ASPIRATION BIOPSY MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL VACUUM ASSISTED BIOPSY MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL OPEN SURGICAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL EXCISIONAL MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL INCISIONAL MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BREAST BIOPSY MARKET 2014-2022($ MILLION)
  • 9. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
  • 10. GLOBAL MRI GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
  • 11. GLOBAL OTHER GUIDANCE TECHNIQUE MARKET 2014-2022($ MILLION)
  • 12. GLOBAL BIOPSY NEEDLES MARKET 2014-2022($ MILLION)
  • 13. GLOBAL GUIDANCE SYSTEMS MARKET 2014-2022($ MILLION)
  • 14. GLOBAL LOCALIZATION WIRES MARKET 2014-2022($ MILLION)
  • 15. GLOBAL OTHER MARKET 2014-2022($ MILLION)
  • 16. NORTH AMERICA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 17. EUROPE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 18. ASIA PACIFIC GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 19. REST OF THE WORLD GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEEDLE BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 2. GLOBAL CORE NEEDLE BIOPSY MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL FINE NEEDLE ASPIRATION BIOPSY MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL VACUUM ASSISTED BIOPSY MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL OPEN SURGICAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL EXCISIONAL MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL INCISIONAL MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BREAST BIOPSY MARKET 2014-2022($ MILLION)
  • 9. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
  • 10. GLOBAL MRI GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
  • 11. GLOBAL OTHER GUIDANCE TECHNIQUE MARKET 2014-2022($ MILLION)
  • 12. GLOBAL BIOPSY NEEDLES MARKET 2014-2022($ MILLION)
  • 13. GLOBAL GUIDANCE SYSTEMS MARKET 2014-2022($ MILLION)
  • 14. GLOBAL LOCALIZATION WIRES MARKET 2014-2022($ MILLION)
  • 15. GLOBAL OTHER MARKET 2014-2022($ MILLION)
  • 16. NORTH AMERICA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 17. UNITED STATES (U.S.) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 18. CANADA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 19. EUROPE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 20. UNITED KINGDOM (UK) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 21. FRANCE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 22. GERMANY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 23. SPAIN GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 24. ITALY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 25. ROE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 26. ASIA PACIFIC GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 27. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 28. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 29. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 30. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 31. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 32. REST OF THE WORLD GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
  • 33. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 34. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 35. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
Back to Top